Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 5,778 | 6,477 | 6,143 | 6,929 | 4,105 |
| Cost of Goods | 5,226 | 3,281 | 2,308 | 2,346 | 2,177 |
| Gross Profit | 552 | 3,196 | 3,835 | 4,583 | 1,928 |
| Operating Expenses | 54,061 | 53,838 | 127,313 | 46,530 | 50,012 |
| Operating Income | -53,283 | -50,361 | -123,170 | -41,601 | -47,907 |
| Interest Expense | 9,459 | 9,520 | 9,080 | 8,886 | 2,684 |
| Other Income | -11,260 | -10,773 | -13,560 | -3,154 | 211 |
| Pre-tax Income | -74,002 | -70,654 | -145,810 | -53,641 | -50,380 |
| Income Tax | -221 | -383 | -178 | -3,123 | -826 |
| Net Income Continuous | -75,212 | -71,845 | -146,529 | -53,715 | -50,454 |
| Minority Interests | -10,797 | -15,083 | -38,458 | -3,941 | -3,126 |
| Net Income | $-64,415 | $-56,762 | $-108,071 | $-49,774 | $-47,328 |
| EPS Basic Total Ops | -0.49 | -0.46 | -0.88 | -0.41 | -0.40 |
| EPS Basic Continuous Ops | -0.58 | -0.59 | -1.20 | -0.43 | -0.43 |
| EPS Diluted Total Ops | -0.50 | -0.47 | -0.88 | -0.41 | -0.40 |
| EPS Diluted Continuous Ops | -0.54 | -0.54 | -1.20 | -0.43 | -0.43 |
| EBITDA(a) | $-50,969 | $-47,898 | $-119,699 | $-40,933 | $-43,527 |